Eli Lilly and Company: all 2,262 studies
Page 20 of 23. Open to participants first (177), then studies with results posted, then the rest; newest registration first within each.
- A Dose-Escalation Study in Participants With Recurrent Malignant GliomaCompletedNCT01682187Phase 1
- Major Depressive Disorder (MDD)CompletedNCT01662817
- A Study of LY3023414 in Participants With Advanced CancerCompletedNCT01655225Phase 1
- The Effect of LY2409021 on Blood Sugar Levels When Glucagon Levels Are Increased in Healthy Male ParticipantsCompletedNCT01606423Phase 1
- A Study of Multiple Increasing Doses of LY2409021 in Participants With Type 2 DiabetesCompletedNCT01606397Phase 1
- A First-in-Human Study of LY2409021 in Healthy Participants and Participants With Type 2 DiabetesCompletedNCT01606371Phase 1
- A Study of LY2875358 in Japanese Participants With Advanced CancerCompletedNCT01602289Phase 1
- A Study of LY2784544 in Participants With Myeloproliferative NeoplasmsActive, not recruitingNCT01594723Phase 2
- A Study of LY2784544 in Healthy Male SubjectsCompletedNCT01577355Phase 1
- A Trial of 18F-AV-133 Positron Emission Tomography (PET) Imaging to Differentiate Subjects With Parkinson's Disease (PD) From Other Movement DisordersCompletedNCT01550484Phase 2/3
- A Study of LY2979165 and LY2140023 in Healthy VolunteersCompletedNCT01524237Phase 1
- Study of LY2784544 Testing Alternative Dosing in Participants With Myeloproliferative NeoplasmsCompletedNCT01520220Phase 1
- A Trial of 18F-AV-133 Positron Emission Tomography (PET)TerminatedNCT01515384Phase 1
- A Study to Evaluate the Safety and Tolerability of LY3000328 in Healthy ParticipantsCompletedNCT01515358Phase 1
- A Trial of 18F-AV-133 and 18F-AV-45 Positron Emission Tomography (PET)CompletedNCT01503944Phase 1/2
- Phase 1/2 Sequentially Staged Safety Study in Healthy Subjects and Subjects With Mild AcneCompletedNCT01490736Phase 1/2
- A Phase I Trial of Enzastaurin (LY317615) in Combination With Carboplatin in Adults With Recurrent GliomasCompletedNCT01445119Phase 1
- A Study in Patients With Type 2 DiabetesWithdrawnNCT01408095Phase 2
- A Study of LY2979165 in Healthy SubjectsCompletedNCT01383967Phase 1
- A Study of LY2875358 in Participants With Advanced CancerCompletedNCT01287546Phase 1
- A Study of LY2801653 in Advanced CancerCompletedNCT01285037Phase 1
- Disposition of 14C-LY2452473 Following Oral Administration in Healthy Human SubjectsCompletedNCT01275157Phase 1
- A Study to Evaluate the Pharmacokinetics of LY2624803 in Subjects With Hepatic ImpairmentTerminatedNCT01257178Phase 1
- A Multiple-Ascending Dose Study in Type 2 Diabetes Mellitus PatientsCompletedNCT01253278Phase 1
- A First Human Dose Study to Investigate Safety and Tolerability of LY2979165 in Healthy VolunteersCompletedNCT01248052Phase 1
- A Study of Brain Receptor Occupancy in Healthy SubjectsCompletedNCT01232439Phase 1
- A Study Combining LY2157299 With Temozolomide-based Radiochemotherapy in Patients With Newly Diagnosed Malignant GliomaCompletedNCT01220271Phase 1/2
- A Biomarker Study of Solanezumab in Patients With and Without Alzheimer'sCompletedNCT01148498Phase 2
- A Study of LY2624587 in Patients With Advanced CancerCompletedNCT01139788Phase 1
- A Study in Myeloproliferative DisordersCompletedNCT01134120Phase 1
- A Phase 1 Study in Participants With Advanced CancerCompletedNCT01115790Phase 1
- A Study in Patients With Advanced or Metastatic CancerCompletedNCT01115751Phase 1
- A Study for Adolescents With Fibromyalgia SyndromeWithdrawnNCT01089621Phase 4
- Head and Neck Cancer Registry (LORHAN)CompletedNCT01080313
- The Cymbalta Pregnancy RegistryCompletedNCT01074151
- Chemotherapy in Treating Patients With Lung CancerCompletedNCT01067794
- Post Marketing Observational Study in Patients With Pulmonary Arterial HypertensionCompletedNCT01066845
- Observational Study in Japanese Type 2 Diabetes PatientsCompletedNCT01055808
- Effect of LY2062430 on the Progression of Alzheimer's DiseaseCompletedNCT00905372Phase 3
- Effect of LY2062430 on the Progression of Alzheimer's DiseaseCompletedNCT00904683Phase 3
- A Study for Patients With Multiple SclerosisTerminatedNCT00870155Phase 2/3
- A Study for Patients With Relapsing Remitting Multiple SclerosisCompletedNCT00869986Phase 2/3
- A Study for Patients With Secondary Progressive Multiple SclerosisCompletedNCT00869726Phase 2/3
- A Safety Study of LY2811376 Single Doses in Healthy SubjectsCompletedNCT00838084Phase 1
- Follow-up Data of Patients Treated With XIGRIS® in FranceCompletedNCT00803231
- Study of IMC-11F8 in Patients With Tumors Who Have Not Responded to Standard TherapyCompletedNCT00801177Phase 1
- Study of IMC-1121B in Patients With Tumors That Have Not Responded to TherapyCompletedNCT00793975Phase 1
- Study of IMC-1121B in Patients With Advanced Solid Tumors Not Responding To Standard TherapyCompletedNCT00786383Phase 1
- A Study of IMC-A12 Every 2 Weeks in Patients With Tumors Who No Longer Respond to Treatment or No Treatment is AvailableCompletedNCT00785941Phase 1
- Safety Study of IMC-18F1,to Treat Advanced Solid Tumors in Subjects That no Longer Respond to Standard TherapyCompletedNCT00782002Phase 1
- Study of IMC-3G3 in Patients With Tumors That Are Not Responding to Standard Therapies or No Therapy is AvailableCompletedNCT00768391Phase 1
- A Study to Determine Whether EGFR Status by FISH Can Predict Results in Non Small Cell Lung Cancer (NSCLC) Patients Treated With Cetuximab, Carboplatin and PaclitaxelWithdrawnNCT00768131Phase 2
- A Study in the Treatment of Acute ManiaTerminatedNCT00767715Phase 4
- A Study of Arzoxifene to Treat Korean Women With OsteoporosisCompletedNCT00767299Phase 2
- A Study of Healthy Subjects to Assess the Effect of LY450139 on Amyloid Beta Peptide Production Rate and or Dose Response.CompletedNCT00765115Phase 1
- Antidepressant Drug Exposure and Risk of Suicide Attempt Resulting in Medical Intervention in US AdultsCompletedNCT00763724
- Back Pain in Patients With Severe OsteoporosisCompletedNCT00761332
- Solanezumab Safety Study in Japanese Patients With Alzheimer's DiseaseCompletedNCT00749216Phase 2
- A Study for Teriparatide in Severe OsteoporosisCompletedNCT00696644
- Effects of Teriparatide in the Treatment of Postmenopausal Women With OsteoporosisCompletedNCT00670501Phase 3
- Comparison of Raloxifene Hydrochloride and Placebo in the Treatment of Postmenopausal Women With OsteoporosisCompletedNCT00670319Phase 3
- Safety Study of Atomoxetine and Cerebrovascular OutcomesCompletedNCT00634439
- Low and Conventional Dose of Somatropin in Growth Hormone Deficient Adult PatientsCompletedNCT00570011Phase 3
- An Open Label Study of Severe Sepsis in AdultsCompletedNCT00568893Phase 4
- The Study of Drotrecogin Alfa (Activated) in Adult Patients With Severe Sepsis at a Low Risk of DeathCompletedNCT00568737Phase 3
- Multi-Country Observational Study to Collect the Frequency of Sexual Dysfunction With Antidepressant Treatment, Either With SSRIs or Duals at 8 Weeks and 6 MonthsCompletedNCT00561509
- 24 Hour Plasma Glucose Profiles Comparing Lispro Mix 75/25 vs. GlargineCompletedNCT00551538Phase 4
- Lispro Mix 25 vs. Glargine in Type 2 DiabeticsCompletedNCT00551356Phase 3
- Enzastaurin and Bevacizumab in Treating Patients With Locally Advanced or Metastatic CancerCompletedNCT00550927Phase 1
- An Observational Study Evaluating Patient Satisfaction and Quality of Life Associated With Switching InsulinCompletedNCT00549887
- Study to Determine Safety and Effectiveness of Tadalafil on Prostate Related Sex Organ/Urinary Tract ProblemsCompletedNCT00547625Phase 2
- Determine If the Stress That Comes With Not Developing an Erection Affects Tadalafil EffectsCompletedNCT00547599Phase 4
- Determine Safety and Effectiveness of Tadalafil in Asian Men When Taken as Needed for Getting and Keeping an ErectionCompletedNCT00547573Phase 3
- To Determine How Different Doses of Tadalafil Work on Getting and Keeping an Erection 26 or 36 Hours After TakingCompletedNCT00547508Phase 3
- Study the Safety and Effectiveness of Tadalafil in Men With Problems Getting or Maintaining an Erection When Taken Prior to Desiring an ErectionCompletedNCT00547495Phase 3
- To Determine Effect and Safety of Tadalafil Taken by Men of Different Races and With Different Diseases When Needed for ErectionsCompletedNCT00547417Phase 3
- Study to Determine a Preference Between Sildenafil or Tadalafil Treatment for Problems Getting an ErectionCompletedNCT00547352Phase 4
- Studying the Preference of Tadalafil to Sildenafil in Men With Problems Getting an Erection Across NationsCompletedNCT00547287Phase 3
- Study the Safety and Effectiveness of Tadalafil in Men With Diabetes Who Have Problems Getting and Keeping an ErectionCompletedNCT00547183Phase 3
- Study For Which Treatment, Tadalafil or Sildenafil, is Preferred For Problems Getting or Maintaining an ErectionCompletedNCT00547092Phase 4
- PTH Comparison in Post Menopausal WomenCompletedNCT00543218Phase 3
- A Study of the Treatment of Postmenopausal Women With OsteoporosisCompletedNCT00543023Phase 3
- Comparison Medications in the Treatment of Postmenopausal Women With OsteoporosisCompletedNCT00542984Phase 3
- Treatment Compliance in Children and Adolescents on ADHD MedicationCompletedNCT00540826
- Performance Status During Treatment With Pemetrexed in Patients With NSCLCCompletedNCT00540241
- Duloxetine - Warfarin Pharmacodynamic StudyCompletedNCT00533026Phase 1
- Bone Marker Changes With Teriparatide/Postmenopausal OsteoporosisCompletedNCT00532545Phase 4
- Long Term Effects of Raloxifene Treatment on Bone QualityCompletedNCT00532428Phase 4
- Carotid Artery Intima-Media Thickness Following Exposure to Raloxifene or PlaceboCompletedNCT00532246Phase 4
- Study of Teriparatide in the Treatment of Postmenopausal Women With OsteoporosisCompletedNCT00532207Phase 3
- An Observational Study of Olanzapine Coated and Orodispersible Tablets Effectiveness in Schizophrenic and Bipolar Outpatients.CompletedNCT00510211
- Duloxetine Versus Duloxetine Plus Non-Drug Therapy for DepressionCompletedNCT00494377Phase 4
- Cisplatin With Gemcitabine With Dexamethasone in Patients With Aggressive Non-Hodgkin's LymphomaCompletedNCT00491127Phase 2
- Intravesical Chemotherapy Treatment of Superficial Bladder CancerCompletedNCT00491114Phase 2
- Neoadjuvant Chemo (Gemcitabine and Cisplatin) With Radical Cystectomy or Radiotherapy in Patients With Bladder CancerCompletedNCT00490880Phase 2
- A Study for Patients With Type 2 Diabetes MellitusCompletedNCT00490854Phase 2/3
- Treatment of Paclitaxel Plus Carboplatin Followed by Gemcitabine Plus Carboplatin for Patients With Epithelial Ovarian CancerCompletedNCT00490711Phase 2
- Trial of Perioperative Chemotherapy (Gemcitabine and Cisplatin) and Adjuvant Chemoradiotherapy (With Weekly Low Dose Gemcitabine) in Patients With Lung Cancer With Positive NodesCompletedNCT00490659Phase 2
- Trial of Gemcitabine and Cisplatin in Patients With Inoperable Biliary Tract CarcinomasCompletedNCT00490399Phase 2
- Trial of Pemetrexed for Patients With Pancreatic Cancer Which Cannot be Treated With Surgery or is MetastaticCompletedNCT00490373Phase 2